Retina Gallery ~ Full Sized Retina Images

Myopic CNVM - lacquer crack - recurrence 6 years later 31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 191 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 240 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 215 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 195 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 225 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 216 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 225 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 217 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 226 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 218 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 181 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 183 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 204 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 189 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 203 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 203 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 207 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 220 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 244 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 221 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 239 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 200 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 238 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 219 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 178 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 191 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 201 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 209 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 191 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 199 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 189 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 216 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 201 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 215 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 233 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 204 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 210 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 202 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 240 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)	Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 yearsvu 217 fois31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment. (0 votes)
40 photos sur 1 page(s)

31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.